1. Bayesian methods for design and analysis of safety trials1. (30th July 2013) Authors: Price, Karen L.; Amy Xia, H.; Lakshminarayanan, Mani; Madigan, David; Manner, David; Scott, John; Stamey, James D.; Thompson, Laura; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bayesian sequential meta‐analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program. (16th December 2013) Authors: Chen, Ming‐Hui; Ibrahim, Joseph G.; Amy Xia, H.; Liu, Thomas; Hennessey, Violeta Journal: Statistics in medicine Issue: Volume 33:Number 9(2014) Page Start: 1600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Guidance on the implementation and reporting of a drug safety Bayesian network meta‐analysis. (30th August 2013) Authors: Ohlssen, David; Price, Karen L.; Amy Xia, H.; Hong, Hwanhee; Kerman, Jouni; Fu, Haoda; Quartey, George; Heilmann, Cory R.; Ma, Haijun; Carlin, Bradley P.; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗